학술논문
PSY67 - Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus: A Cost-Effectiveness Model
Document Type
Abstract
Author
Source
In Value in Health October-November 2017 20(9):A556-A556
Subject
Language
ISSN
1098-3015